|
ATP6V1G1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.139000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.063010E-01 |
| Normal-vs-Stage2 |
5.543800E-01 |
| Normal-vs-Stage3 |
5.072800E-01 |
| Normal-vs-Stage4 |
4.736200E-01 |
| Stage1-vs-Stage2 |
7.808000E-01 |
| Stage1-vs-Stage3 |
4.665800E-01 |
| Stage1-vs-Stage4 |
5.118200E-02 |
| Stage2-vs-Stage3 |
8.758400E-01 |
| Stage2-vs-Stage4 |
2.972600E-01 |
| Stage3-vs-Stage4 |
2.358400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.225000E-01 |
| Normal-vs-AfricanAmerican |
4.452600E-01 |
| Normal-vs-Asian |
7.580600E-01 |
| Caucasian-vs-AfricanAmerican |
6.428000E-01 |
| Caucasian-vs-Asian |
7.196200E-01 |
| AfricanAmerican-vs-Asian |
5.481600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.865200E-01 |
| Normal-vs-Female |
1.061750E-01 |
| Male-vs-Female |
1.171990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.315030E-01 |
| Normal-vs-Age(41-60Yrs) |
3.523000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.747800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.809400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.173200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.730000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.237190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.429200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.935410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.753800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.958400E-01 |
| Classical-VS-Follicular |
2.328200E-01 |
| Classical-VS-Other |
9.168200E-01 |
| Classical-VS-Normal |
2.663800E-01 |
| Tall-VS-Follicular |
3.996600E-01 |
| Tall-VS-Other |
9.162400E-01 |
| Tall-VS-Normal |
4.803000E-01 |
| Follicular-VS-Other |
6.454400E-01 |
| Follicular-VS-Normal |
7.112200E-02 |
| Other-VS-Normal |
7.504600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.949400E-01 |
| Normal-vs-N1 |
7.798800E-01 |
| N0-vs-N1 |
3.132400E-01 |
|
|
